Nucleic acid degradation as barrier to gene delivery: a guide to understand and overcome nuclease activity

H Zhang, J Vandesompele, K Braeckmans… - Chemical Society …, 2024 - pubs.rsc.org
Gene therapy is on its way to revolutionize the treatment of both inherited and acquired
diseases, by transferring nucleic acids to correct a disease-causing gene in the target cells …

Cardiac arrhythmias in post-COVID syndrome: prevalence, pathology, diagnosis, and treatment

A Huseynov, I Akin, D Duerschmied, RE Scharf - Viruses, 2023 - mdpi.com
An increase in post-COVID patients with late sequelae of acute COVID-19 infection is
emerging as an ongoing challenge for physicians and healthcare professionals. Since the …

Epidemiological and clinical features of SARS-CoV-2 omicron variant infection in Quanzhou, Fujian province: a retrospective study

H Zhang, Z Weng, Y Zheng, M Zheng, W Chen, H He… - Scientific Reports, 2023 - nature.com
Epidemiological and clinical data of patients infected with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) Omicron variant (BA. 2) admitted to three …

No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines

A Yalcinkaya, M Cavalli, A Cederholm… - npj Vaccines, 2024 - nature.com
Type I interferons act as gatekeepers against viral infection, and autoantibodies that
neutralize these signaling molecules have been associated with COVID-19 severity and …

A landscape on disorders following different COVID-19 vaccination: a systematic review of Iranian case reports

M Sadat Larijani, D Doroud, M Banifazl… - European Journal of …, 2023 - Springer
There have been massive studies to develop an effective vaccine against SARS-CoV-2
which fortunately led to manage the recent pandemic, COVID-19. According to the quite …

Ocular Manifestations of COVID-19

H Ng, D Scott, H Danesh-Meyer, J Smith… - Progress in Retinal and …, 2024 - Elsevier
There is an increasing body of knowledge regarding how COVID-19 may be associated with
ocular disease of varying severity and duration. This article discusses the literature on the …

Murine alveolar macrophages rapidly accumulate intranasally administered SARS-CoV-2 Spike protein leading to neutrophil recruitment and damage

C Park, IY Hwang, SLS Yan, S Vimonpatranon, D Wei… - Elife, 2024 - elifesciences.org
Abstract The trimeric SARS-CoV-2 Spike protein mediates viral attachment facilitating cell
entry. Most COVID-19 vaccines direct mammalian cells to express the Spike protein or …

Recovery from antibody-mediated biliary ductopenia and multiorgan inflammation after COVID-19 vaccination

A Chang, YM Jeng, CM Ho, PH Lee - npj Vaccines, 2024 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has caused significant
morbidity and mortality. Spike messenger RNA (mRNA)–based vaccines against severe …

[HTML][HTML] Recurring SARS-CoV-2 variants: an update on post-pandemic, co-infections and immune response

A Verma, A Manojkumar, A Dhasmana… - …, 2024 - ncbi.nlm.nih.gov
The post-pandemic era following the global spread of the SARS-CoV-2 virus has brought
about persistent concerns regarding recurring coinfections. While significant strides in …

Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey

PA Jarrot, A Mirouse, S Ottaviani, S Cadiou… - Human Vaccines & …, 2024 - Taylor & Francis
We conducted a national in-depth analysis including pharmacovigilance reports and clinical
study to assess the reporting rate (RR) and to determine the clinical profile of polymyalgia …